{"id":"vincristine-carboplatin-and-etoposide","safety":{"commonSideEffects":[{"rate":null,"effect":"Myelosuppression (neutropenia, thrombocytopenia, anemia)"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Peripheral neuropathy"},{"rate":null,"effect":"Alopecia"},{"rate":null,"effect":"Mucositis"},{"rate":null,"effect":"Infection"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Vincristine is a vinca alkaloid that binds tubulin and prevents microtubule assembly, arresting cells in metaphase. Carboplatin is a platinum-based agent that forms DNA crosslinks, causing strand breaks and cell death. Etoposide is a topoisomerase II inhibitor that prevents DNA religation, leading to double-strand breaks. Together, these agents provide synergistic cytotoxic activity against rapidly dividing cancer cells.","oneSentence":"This combination chemotherapy regimen kills cancer cells by disrupting microtubule formation (vincristine), damaging DNA (carboplatin), and inhibiting topoisomerase II (etoposide).","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:40:37.256Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Pediatric cancers (likely lymphomas, leukemias, or solid tumors based on St. Jude focus)"}]},"trialDetails":[{"nctId":"NCT06172296","phase":"PHASE3","title":"Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-04-19","conditions":"Ganglioneuroblastoma, Nodular, Neuroblastoma","enrollment":478},{"nctId":"NCT02114229","phase":"PHASE2","title":"Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2014-05-14","conditions":"Malignant Rhabdoid Tumor, Atypical Teratoid Rhabdoid Tumor","enrollment":125},{"nctId":"NCT06193759","phase":"PHASE1","title":"Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)","status":"RECRUITING","sponsor":"Children's National Research Institute","startDate":"2024-09-20","conditions":"Medulloblastoma, Childhood, Atypical Teratoid/Rhabdoid Tumor of CNS, Embryonal Tumor With Multilayered Rosettes","enrollment":12},{"nctId":"NCT06401330","phase":"PHASE3","title":"A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2025-04-15","conditions":"Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor, Stage III Mixed Cell Type Kidney Wilms Tumor","enrollment":1656},{"nctId":"NCT04663347","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Genmab","startDate":"2020-11-03","conditions":"Diffuse Large B-Cell Lymphoma, Follicular Lymphoma","enrollment":543},{"nctId":"NCT03126916","phase":"PHASE3","title":"Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2018-05-14","conditions":"Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neuroblastoma","enrollment":750},{"nctId":"NCT06942039","phase":"EARLY_PHASE1","title":"Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation","status":"RECRUITING","sponsor":"C17 Council","startDate":"2025-09-23","conditions":"CNS Embryonal Tumor, CNS, Medulloblastoma, Atypical Teratoid Rhabdoid Tumor","enrollment":15},{"nctId":"NCT04322318","phase":"PHASE2","title":"A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2020-10-19","conditions":"Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor, Stage II Kidney Wilms Tumor","enrollment":256},{"nctId":"NCT05504291","phase":"PHASE2","title":"A Study to Give Treatment Inside the Eye to Treat Retinoblastoma","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2022-11-04","conditions":"Bilateral Retinoblastoma, Childhood Intraocular Retinoblastoma, Group D Retinoblastoma","enrollment":26},{"nctId":"NCT05535166","phase":"PHASE2","title":"Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2022-12-20","conditions":"Medulloblastoma","enrollment":130},{"nctId":"NCT02875314","phase":"PHASE4","title":"HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Parth Patel","startDate":"2015-09","conditions":"Medulloblastoma, Central Nervous System Embryonal Tumors","enrollment":250},{"nctId":"NCT06528496","phase":"PHASE2","title":"N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2024-07-22","conditions":"High-risk Neuroblastoma, Neuroblastoma, Childhood Neuroblastoma","enrollment":45},{"nctId":"NCT00336024","phase":"PHASE3","title":"Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2007-10-22","conditions":"Anaplastic Medulloblastoma, Medulloblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified","enrollment":91},{"nctId":"NCT00602667","phase":"PHASE2","title":"Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2007-12-17","conditions":"Brain and Central Nervous System Tumors","enrollment":293},{"nctId":"NCT02870907","phase":"PHASE2","title":"Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut Curie","startDate":"2010-03-18","conditions":"Retinoblastoma","enrollment":195},{"nctId":"NCT03533582","phase":"PHASE3","title":"Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2018-05-24","conditions":"Childhood Hepatocellular Carcinoma, Childhood Malignant Liver Neoplasm, Fibrolamellar Carcinoma","enrollment":537},{"nctId":"NCT07291102","phase":"PHASE3","title":"Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma","status":"NOT_YET_RECRUITING","sponsor":"Nationwide Children's Hospital","startDate":"2026-07-01","conditions":"Medulloblastoma","enrollment":96},{"nctId":"NCT06520163","phase":"PHASE3","title":"Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma","status":"RECRUITING","sponsor":"The Affiliated People's Hospital of Ningbo University","startDate":"2024-08-01","conditions":"Non-Hodgkin's Lymphoma, Hematopoietic Stem Cell Mobilization","enrollment":99},{"nctId":"NCT04681417","phase":"PHASE2, PHASE3","title":"Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome","status":"RECRUITING","sponsor":"Institut Curie","startDate":"2021-03-25","conditions":"Retinoblastoma","enrollment":225},{"nctId":"NCT02866136","phase":"PHASE2","title":"Conservative Treatments of Retinoblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut Curie","startDate":"2012-02","conditions":"Retinoblastoma, Children, Retinal Neoplasm","enrollment":133},{"nctId":"NCT00077285","phase":"PHASE2","title":"Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2003-10","conditions":"Sarcoma","enrollment":65},{"nctId":"NCT01096368","phase":"PHASE3","title":"Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2010-05-07","conditions":"Anaplastic Ependymoma, Brain Ependymoma, Cellular Ependymoma","enrollment":479},{"nctId":"NCT03786783","phase":"PHASE2","title":"Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-03-04","conditions":"Ganglioneuroblastoma, High Risk Neuroblastoma","enrollment":42},{"nctId":"NCT07187960","phase":"PHASE3","title":"Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.","startDate":"2025-11","conditions":"Follicular Lymphoma","enrollment":228},{"nctId":"NCT00186888","phase":"PHASE3","title":"Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2005-04-07","conditions":"Retinoblastoma, Retinal Neoplasm","enrollment":107},{"nctId":"NCT07081022","phase":"PHASE2","title":"JS203 Combination Regimens in B-Cell Non-Hodgkin's Lymphoma","status":"RECRUITING","sponsor":"Shanghai Junshi Bioscience Co., Ltd.","startDate":"2025-08-17","conditions":"B-cell Non-Hodgkin's Lymphoma","enrollment":180},{"nctId":"NCT04947501","phase":"EARLY_PHASE1","title":"A Study of N9 Chemotherapy in Children With Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-06-22","conditions":"Neuroblastoma, Pediatric Cancer","enrollment":26},{"nctId":"NCT04221035","phase":"PHASE3","title":"High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)","status":"RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2019-11-05","conditions":"High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy","enrollment":800},{"nctId":"NCT04668365","phase":"PHASE2","title":"Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma","status":"SUSPENDED","sponsor":"Henan Cancer Hospital","startDate":"2020-12-25","conditions":"Diffuse Large B Cell Lymphoma, CD79A Gene Mutation, CD79B Gene Mutation","enrollment":59},{"nctId":"NCT03632135","phase":"PHASE3","title":"Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma","status":"COMPLETED","sponsor":"Cordgenics, LLC","startDate":"2018-05-20","conditions":"Recurrent Glioblastoma","enrollment":78},{"nctId":"NCT03669783","phase":"PHASE3","title":"Clinical Trial for Patients With a Stage IV Childhood Renal Tumor, Comparing Upfront Vincristine, Actinomycin-D and Doxorubicin (Standard Arm) With Upfront Vincristine, Carboplatin and Etoposide (Experimental Arm)","status":"RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2023-02-03","conditions":"Childhood Renal Tumor","enrollment":110},{"nctId":"NCT00554788","phase":"PHASE3","title":"Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2008-05-06","conditions":"Extraocular Retinoblastoma","enrollment":60},{"nctId":"NCT06669013","phase":"PHASE3","title":"Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas","status":"RECRUITING","sponsor":"N.N. Petrov National Medical Research Center of Oncology","startDate":"2021-05-20","conditions":"Bone Sarcoma, Embryonal Rhabdomyosarcoma, Alveolar Rhabdomyosarcoma","enrollment":40},{"nctId":"NCT02348216","phase":"PHASE1, PHASE2","title":"Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Kite, A Gilead Company","startDate":"2015-04-21","conditions":"Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma (TFL)","enrollment":307},{"nctId":"NCT03017326","phase":"PHASE3","title":"Paediatric Hepatic International Tumour Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Birmingham","startDate":"2017-08-24","conditions":"Hepatoblastoma, Carcinoma, Hepatocellular","enrollment":450},{"nctId":"NCT02265770","phase":"PHASE2, PHASE3","title":"An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma","status":"RECRUITING","sponsor":"Centre Leon Berard","startDate":"2015-06-02","conditions":"Childhood Ependymoma","enrollment":536},{"nctId":"NCT00653068","phase":"PHASE3","title":"Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2009-02-10","conditions":"Childhood Atypical Teratoid/Rhabdoid Tumor","enrollment":70},{"nctId":"NCT00110110","phase":"PHASE2","title":"Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Hospital for Sick Children","startDate":"2004-06","conditions":"Retinoblastoma","enrollment":71},{"nctId":"NCT01783535","phase":"PHASE2","title":"Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2013-06-19","conditions":"Retinoblastoma","enrollment":174},{"nctId":"NCT01906814","phase":"PHASE3","title":"Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2013-08","conditions":"Retinoblastoma","enrollment":179},{"nctId":"NCT06263530","phase":"","title":"Prognostic Significance of ctDNA in HL","status":"RECRUITING","sponsor":"Interni hematologicka klinika FNKV","startDate":"2022-01-02","conditions":"Prognostic Cancer Model","enrollment":500},{"nctId":"NCT00274924","phase":"PHASE2","title":"Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"2006-09-26","conditions":"Lymphoma","enrollment":100},{"nctId":"NCT02017964","phase":"PHASE2","title":"Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2013-12-24","conditions":"Desmoplastic/Nodular Medulloblastoma, Medulloblastoma, Medulloblastoma With Extensive Nodularity","enrollment":26},{"nctId":"NCT02703272","phase":"PHASE3","title":"A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma","status":"TERMINATED","sponsor":"Janssen Research & Development, LLC","startDate":"2016-07-01","conditions":"Lymphoma, Non-Hodgkin","enrollment":72},{"nctId":"NCT00712582","phase":"PHASE2","title":"Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2008-07-01","conditions":"Non-Hodgkin's Lymphoma","enrollment":96},{"nctId":"NCT02639650","phase":"PHASE3","title":"Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor","status":"UNKNOWN","sponsor":"Weiguo Lv","startDate":"2016-03-01","conditions":"Gestational Trophoblastic Neoplasms","enrollment":214},{"nctId":"NCT00567567","phase":"PHASE3","title":"Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2007-11-05","conditions":"Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma","enrollment":665},{"nctId":"NCT00867178","phase":"PHASE1","title":"Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2009-02-25","conditions":"Medulloblastoma, Pineoblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified","enrollment":33},{"nctId":"NCT00072384","phase":"PHASE3","title":"Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular Retinoblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2007-04-16","conditions":"Intraocular Retinoblastoma","enrollment":30},{"nctId":"NCT00324467","phase":"PHASE2","title":"Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment","status":"UNKNOWN","sponsor":"British Columbia Cancer Agency","startDate":"2006-08","conditions":"Lymphoma, Non-Hodgkin, Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma","enrollment":150},{"nctId":"NCT00002611","phase":"PHASE3","title":"Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1995-07","conditions":"Kidney Cancer","enrollment":3031},{"nctId":"NCT03986463","phase":"","title":"CIrculating Tumour DNA in Lung Cancer (CITaDeL): Optimizing Sensitivity and Clinical Utility","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2019-05-01","conditions":"Lung Neoplasms, Lung Cancer, Neoplasm of Lung","enrollment":40},{"nctId":"NCT00335738","phase":"PHASE3","title":"Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2005-12","conditions":"Intraocular Retinoblastoma","enrollment":331},{"nctId":"NCT02788201","phase":"PHASE2","title":"Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-03-27","conditions":"Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Neoplasms","enrollment":8},{"nctId":"NCT01704716","phase":"PHASE3","title":"High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)","status":"RECRUITING","sponsor":"St. Anna Kinderkrebsforschung","startDate":"2002-02","conditions":"Neuroblastoma","enrollment":3300},{"nctId":"NCT02116959","phase":"PHASE1","title":"Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2014-07-23","conditions":"Advanced Intra-Ocular Retinoblastoma, Retinoblastoma","enrollment":6},{"nctId":"NCT01014767","phase":"PHASE3","title":"Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors","status":"TERMINATED","sponsor":"Tufts Medical Center","startDate":"2009-11","conditions":"Brain Cancer, Choroid Plexus Tumors","enrollment":27},{"nctId":"NCT00027846","phase":"PHASE2","title":"Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2003-08","conditions":"Brain Tumor, Central Nervous System Tumor","enrollment":378},{"nctId":"NCT00809341","phase":"PHASE2","title":"R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2009-01","conditions":"Non-Hodgkin's Lymphoma","enrollment":27},{"nctId":"NCT00276640","phase":"NA","title":"Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas","status":"COMPLETED","sponsor":"Societe Internationale d'Oncologie Pediatrique","startDate":"2004-04-01","conditions":"Primary Central Nervous System Neoplasms","enrollment":3417},{"nctId":"NCT00335556","phase":"PHASE2","title":"Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2006-06","conditions":"Childhood Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Clear Cell Sarcoma of the Kidney","enrollment":291},{"nctId":"NCT03042429","phase":"PHASE3","title":"Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2007-01-01","conditions":"Neuroblastoma","enrollment":360},{"nctId":"NCT00039195","phase":"PHASE2","title":"Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2006-11","conditions":"Lymphoma","enrollment":98},{"nctId":"NCT00003273","phase":"PHASE2","title":"Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"1997-11","conditions":"Brain and Central Nervous System Tumors, Neuroblastoma, Retinoblastoma","enrollment":""},{"nctId":"NCT00526318","phase":"NA","title":"Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma","status":"UNKNOWN","sponsor":"German Society for Pediatric Oncology and Hematology GPOH gGmbH","startDate":"2007-01","conditions":"Neuroblastoma","enrollment":360},{"nctId":"NCT00002610","phase":"PHASE3","title":"Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1996-01","conditions":"Kidney Cancer","enrollment":203},{"nctId":"NCT00002740","phase":"PHASE1","title":"Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1996-05","conditions":"Neuroblastoma","enrollment":30},{"nctId":"NCT01535183","phase":"PHASE2","title":"Irinotecan Combination Chemotherapy for Refractory or Relapsed Brain Tumor in Children and Adolescents","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2012-01","conditions":"Brain Tumor","enrollment":40},{"nctId":"NCT00030719","phase":"PHASE3","title":"Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma","status":"UNKNOWN","sponsor":"University of Leicester","startDate":"2001-12","conditions":"Neuroblastoma","enrollment":175},{"nctId":"NCT00047138","phase":"PHASE3","title":"Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor","status":"UNKNOWN","sponsor":"University of Leicester","startDate":"2001-01","conditions":"Kidney Cancer","enrollment":350},{"nctId":"NCT01899066","phase":"PHASE2","title":"Efficacy Study of Lucentis in the Treatment of Retinoblastoma","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2013-07","conditions":"Retinoblastoma","enrollment":20},{"nctId":"NCT00003141","phase":"PHASE1","title":"Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1998-03","conditions":"Brain Tumors, Central Nervous System Tumors, Neuroblastoma","enrollment":94},{"nctId":"NCT00017368","phase":"PHASE2","title":"Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2001-04","conditions":"Neuroblastoma","enrollment":42},{"nctId":"NCT00303810","phase":"NA","title":"Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2001-01","conditions":"Brain and Central Nervous System Tumors","enrollment":567},{"nctId":"NCT00002822","phase":"PHASE3","title":"Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Medical Research Council","startDate":"1996-03","conditions":"Lung Cancer","enrollment":400},{"nctId":"NCT00002802","phase":"PHASE3","title":"Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"1990-07","conditions":"Neuroblastoma","enrollment":500},{"nctId":"NCT00392886","phase":"PHASE3","title":"Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors","status":"UNKNOWN","sponsor":"Children's Hospital Los Angeles","startDate":"2004-03","conditions":"Brain and Central Nervous System Tumors","enrollment":120},{"nctId":"NCT00003859","phase":"PHASE3","title":"Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS","status":"COMPLETED","sponsor":"Societe Internationale d'Oncologie Pediatrique","startDate":"1992-04","conditions":"Brain and Central Nervous System Tumors","enrollment":230},{"nctId":"NCT00002898","phase":"PHASE3","title":"Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma","status":"COMPLETED","sponsor":"Societe Internationale d'Oncologie Pediatrique","startDate":"1995-01","conditions":"Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma","enrollment":400},{"nctId":"NCT00025441","phase":"PHASE2","title":"Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors","status":"COMPLETED","sponsor":"Societe Internationale d'Oncologie Pediatrique","startDate":"1998-11","conditions":"Ovarian Cancer, Sarcoma, Small Intestine Cancer","enrollment":""},{"nctId":"NCT00025610","phase":"PHASE2","title":"Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma","status":"COMPLETED","sponsor":"European Infant Neuroblastoma Study Group - 1999","startDate":"1999-07","conditions":"Neuroblastoma","enrollment":""},{"nctId":"NCT00025649","phase":"PHASE2","title":"Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma","status":"COMPLETED","sponsor":"European Infant Neuroblastoma Study Group - 1999","startDate":"1999-07","conditions":"Neuroblastoma","enrollment":""},{"nctId":"NCT00287950","phase":"NA","title":"Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma","status":"UNKNOWN","sponsor":"Children's Cancer and Leukaemia Group","startDate":"1992-09","conditions":"Neuroblastoma","enrollment":120},{"nctId":"NCT00360750","phase":"NA","title":"Chemotherapy With or Without Radiation Therapy or Observation in Treating Young Patients With Advanced Retinoblastoma Who Have Undergone Surgery to Remove the Eye","status":"UNKNOWN","sponsor":"Children's Cancer and Leukaemia Group","startDate":"2005-09","conditions":"Retinoblastoma","enrollment":""},{"nctId":"NCT00301782","phase":"PHASE2","title":"Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors","status":"COMPLETED","sponsor":"Medical Research Council","startDate":"2005-06","conditions":"Extragonadal Germ Cell Tumor, Teratoma, Testicular Germ Cell Tumor","enrollment":88},{"nctId":"NCT00379457","phase":"PHASE3","title":"Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma","status":"UNKNOWN","sponsor":"European Paediatric Soft Tissue Sarcoma Study Group","startDate":"2006-06","conditions":"Sarcoma","enrollment":600},{"nctId":"NCT00410631","phase":"PHASE3","title":"Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma","status":"UNKNOWN","sponsor":"German Society for Pediatric Oncology and Hematology GPOH gGmbH","startDate":"2004-10","conditions":"Neuroblastoma","enrollment":642},{"nctId":"NCT00017225","phase":"PHASE2","title":"Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma","status":"COMPLETED","sponsor":"German Society for Pediatric Oncology and Hematology GPOH gGmbH","startDate":"1997-05","conditions":"Neuroblastoma","enrollment":""},{"nctId":"NCT00025103","phase":"PHASE2","title":"Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney","status":"UNKNOWN","sponsor":"Children's Cancer and Leukaemia Group","startDate":"2001-05","conditions":"Kidney Cancer","enrollment":75},{"nctId":"NCT00365755","phase":"PHASE3","title":"Combination Chemotherapy in Treating Young Patients Who Are Undergoing Surgery and an Autologous Bone Marrow Transplant for Disseminated Neuroblastoma","status":"COMPLETED","sponsor":"Children's Cancer and Leukaemia Group","startDate":"","conditions":"Neuroblastoma","enrollment":""},{"nctId":"NCT00416676","phase":"PHASE3","title":"Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 Neuroblastoma","status":"UNKNOWN","sponsor":"Children's Cancer and Leukaemia Group","startDate":"","conditions":"Neuroblastoma","enrollment":30},{"nctId":"NCT00417053","phase":"PHASE3","title":"Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant","status":"UNKNOWN","sponsor":"Children's Cancer and Leukaemia Group","startDate":"","conditions":"Neuroblastoma","enrollment":""},{"nctId":"NCT00002675","phase":"PHASE2","title":"Chemotherapy in Treating Patients With Retinoblastoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"1995-05","conditions":"Retinoblastoma","enrollment":50},{"nctId":"NCT00002489","phase":"PHASE2","title":"Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"1991-10","conditions":"Extragonadal Germ Cell Tumor, Ovarian Cancer","enrollment":""},{"nctId":"NCT00003541","phase":"PHASE1, PHASE2","title":"Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"1998-06","conditions":"Lymphoma","enrollment":24},{"nctId":"NCT00004188","phase":"PHASE3","title":"Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2001-02","conditions":"Neuroblastoma","enrollment":495},{"nctId":"NCT00040872","phase":"PHASE2","title":"Multiple Therapies in Treating Patients With Advanced Neuroblastoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2000-06","conditions":"Neuroblastoma","enrollment":""},{"nctId":"NCT00889018","phase":"NA","title":"Trial Comparing Two Carboplatin Doses in Groups C and D Intraocular Retinoblastoma","status":"UNKNOWN","sponsor":"All India Institute of Medical Sciences","startDate":"2009-04","conditions":"Intraocular Retinoblastoma","enrollment":60},{"nctId":"NCT00165139","phase":"PHASE2","title":"Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"1996-01","conditions":"Neuroblastoma, Ewings Sarcoma, Non-rhabdomyosarcoma Soft Tissue Sarcoma","enrollment":20},{"nctId":"NCT00187070","phase":"NA","title":"Large Cell Lymphoma Pilot Study III","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"1997-12","conditions":"Lymphoma, Large Cell, Lymphoma, Non-Hodgkin","enrollment":8}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Onconvin and Paraplatin and Vepesid"],"phase":"phase_3","status":"active","brandName":"Vincristine, Carboplatin and Etoposide","genericName":"Vincristine, Carboplatin and Etoposide","companyName":"St. Jude Children's Research Hospital","companyId":"st-jude-children-s-research-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination chemotherapy regimen kills cancer cells by disrupting microtubule formation (vincristine), damaging DNA (carboplatin), and inhibiting topoisomerase II (etoposide). Used for Pediatric cancers (likely lymphomas, leukemias, or solid tumors based on St. Jude focus).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}